![]() |
|
|
Vol. 12, Issue 4, 1079-1091, April 2001
Induces Nuclear Import of Smad3 in
an Importin-
1 and Ran-dependent Manner


*Ludwig Institute for Cancer Research, SE-751 24 Uppsala, Sweden;
and
Department of Cell Biology and Neuroscience, Graduate
School of Medicine, Osaka University, Suita, Osaka 565-0871, Japan
| |
ABSTRACT |
|---|
|
|
|---|
Smad proteins are cytoplasmic signaling effectors of transforming
growth factor-
(TGF-
) family cytokines and regulate gene transcription in the nucleus. Receptor-activated Smads (R-Smads) become
phosphorylated by the TGF-
type I receptor. Rapid and precise
transport of R-Smads to the nucleus is of crucial importance for signal
transduction. By focusing on the R-Smad Smad3 we demonstrate that 1)
only activated Smad3 efficiently enters the nucleus of permeabilized
cells in an energy- and cytosol-dependent manner. 2) Smad3, via its
N-terminal domain, interacts specifically with importin-
1 and only
after activation by receptor. In contrast, the unique insert of exon3
in the N-terminal domain of Smad2 prevents its association with
importin-
1. 3) Nuclear import of Smad3 in vivo requires the action
of the Ran GTPase, which mediates release of Smad3 from the complex
with importin-
1. 4) Importin-
1, Ran, and p10/NTF2 are sufficient
to mediate import of activated Smad3. The data describe a pathway
whereby Smad3 phosphorylation by the TGF-
receptor leads to enhanced
interaction with importin-
1 and Ran-dependent import and release
into the nucleus. The import mechanism of Smad3 shows distinct features
from that of the related Smad2 and the structural basis for this
difference maps to the divergent sequences of their N-terminal domains.
| |
INTRODUCTION |
|---|
|
|
|---|
Transforming growth factor-
s (TGF-
s) are multifunctional
peptide growth factors that regulate cell proliferation,
differentiation, and death, and are involved in normal development and
several disease conditions (Roberts and Sporn, 1990
; Massagué
et al., 2000
). TGF-
signals via plasma membrane receptor
serine/threonine kinases that activate, by phosphorylation, the
receptor-activated Smad (R-Smad) proteins at their C-terminal conserved
SSXS motifs (Massagué and Chen, 2000
; ten Dijke et
al., 2000
). The activated R-Smads rapidly translocate to the
nucleus and simultaneously carry along the common mediator (Co)-Smad.
The nuclear complex of Smads associates directly with specific DNA
sequences and with a large number of transcription factors, leading to
target gene regulation (Attisano and Wrana, 2000
; Massagué and
Wotton, 2000
; ten Dijke et al., 2000
). Although the nuclear
import of R-Smads is of crucial importance to this signaling pathway,
its nature and details have just started to surface.
The pathway of regulated nuclear import of proteins is
well-explored (Mattaj and Englmeier, 1998
; Görlich and Kutay,
1999
). Accordingly, protein cargoes associate with importin carriers, which traverse the nuclear pores via nucleoporin-mediated associations (Rout et al., 2000
). In the nucleoplasm, the protein cargo
is released by the action of the small GTPase Ran that interacts with
the importin carrier and disrupts the cargo-importin complex. Nuclear
import is energetically driven by a precise gradient of Ran-GTP, which
increases from the cytoplasmic toward the nuclear side of the pore
(Görlich and Kutay, 1999
; Yoneda et al., 1999
). For
many proteins, regulated nuclear import depends on a nuclear localization signal (NLS) rich in basic amino acids, which interacts specifically with importin-
, an adaptor molecule that mediates interaction with importin-
, the primary carrier that associates with
various nucleoporins and Ran (Mattaj and Englmeier, 1998
; Görlich
and Kutay, 1999
). In other cases, the cargo protein interacts directly
with importin-
or other members of this family of carriers via a
positively charged NLS-like motif or via uncharacterized protein
domains of the cargo (Görlich and Kutay, 1999
; Yoneda et
al., 1999
). Finally, certain proteins do not require importins for
their nuclear import but seem to associate directly with nucleoporins (Görlich and Kutay, 1999
).
Smad proteins consist of conserved N-terminal, Mad-homology (MH)1, and
C-terminal, MH2 domains that associate with each other within the same
Smad molecule conferring an autoinhibitory property to the protein
(Heldin et al., 1997
; Massagué et al.,
2000
). Phosphorylation of the carboxyl-terminal serines of the R-Smad SSXS motif by the type I receptor serine/threonine kinase leads to
conformational changes of the MH1 and MH2 domains and functional activation (Heldin et al., 1997
). One primary function of
the MH1 domain of most Smads is to bind DNA sequences via its
-hairpin loop (Shi et al., 1998
; Massagué and
Wotton, 2000
). A conserved lysine-rich motif resides in the N-terminal
half of the MH1 domain of most Smads (Shi et al., 1998
; Xiao
et al., 2000a
). This motif resembles the classic simian
virus 40 large T antigen NLS and it was recently shown to
function as an NLS in Smad3 (Xiao et al., 2000a
). In
contrast, another recent report described the Smad2 import mechanism as
NLS-independent (Xu et al., 2000
). These reports provide
contradictory evidence for Smad nuclear import and leave the precise
import mechanism still open for investigation. Of great impact is the
question whether the Ran GTPase regulates Smad import. To address these
fundamental issues we focused on Smad3, a central effector of the
TGF-
signaling pathway. We describe a mechanism of regulated Smad3
nuclear import via the nonclassical importin-
/Ran pathway. We also
provide molecular evidence for the difference of import mechanisms
between Smad2 and Smad3.
| |
MATERIALS AND METHODS |
|---|
|
|
|---|
Reagent and Antibodies
TGF-
1 was from Dr. N. Ferrara (Genentech, San Francisco, CA).
Bone morphogenetic protein 7 (BMP-7) was from Dr. K. Sampath (Creative
Biomolecules, Hopkinton, MA). Purified baculoviral Smad3 and TGF-
type I receptor-phosphorylated Smad3 proteins were from Drs. F.M.
Hoffman and A. Comer (Johnson et al., 1999
). Restriction enzymes and DNA-modifying enzymes were from New England Biolabs (Beverly, MA) or MBI Fermentas Inc. (St. Leou-Rot, Germany). The glutathione S-transferase (GST) purification kit was from
Amersham Pharmacia Biotech (Uppsala, Sweden).
Isopropyl-
-D-thiogalactopyranoside and
digitonin were from Calbiochem (San Diego, CA). All reagents for cell
culture (DMEM, fetal bovine serum [FBS], trypsin-EDTA, and
phosphate-buffered saline) were from Life Technologies (Gaithersburg, MD). Monoclonal anti-Flag (M2, F-3165, and M5, F-4042) antibodies and
4',6-diamidino-2-phenylindole were from Sigma (St. Louis, MO).
Monoclonal anti-myc antibody was produced by the 9E10 hybridoma cell
clone. Anti-histidine antibody (Penta-His) was from Qiagen (Chatsworth,
CA). Anti-phospho-serine rabbit polyclonal antibody (Poly-Z-PS1) was
from Zymed Laboratories (South San Francisco, CA). Anti-Smad2/3
antibody (clone H-2) was from Santa Cruz Biotechnology (Santa Cruz,
CA). Anti-phospho-Smad2/3 rabbit polyclonal antisera were as described
(Piek et al., 1999
). Anti-mouse horseradish peroxidase-,
anti-mouse Cy3-, and anti-mouse tetramethylrhodamine isothiocyanate-conjugated secondary antibodies from Amersham Pharmacia Biotech, Molecular Probes (Eugene, OR), and DAKO (Carpinteria, CA), respectively.
Plasmid Constructions
The expression vector pcDNA3 encoding the nontagged Smad2,
nontagged Smad3, 6myc-tagged human Smad3, the deletion mutants of Smad3
MH1 plus linker (1-229), Smad3 linker plus MH2 (135-424), Smad3 MH1
(1-134), Smad3 linker (135-229), Smad3 MH2 (230-424) were generously
provided by Dr S. Itoh of our institute. The expression vector
pcDNA3-HA-CA-ALK5 was described earlier (Nakao et al., 1997
). The three MH1 domain Smad3-Smad2 chimeras in pcDNA3.1
(Smad2
TID, Smad2
GAG, and Smad2
GAG
TID) were from Dr. J.-M.
Gauthier exactly as described (Dennler et al., 1999
).
To construct pGEX4T-1-Flag-Smad3 plasmid, the
BamHI-XhoI fragment encoding Flag-tagged human
Smad3 was obtained from pcDNA3-FlagSmad3 (Morén et
al., 2000
) and subcloned into the BamHI-XhoI
sites of pGEX-4T-1 (Amersham Pharmacia Biotech). To generate
pGEX-FlagSmad3D, the BglII-NotI fragment (amino
acids 342-425) of pMX-IRES-GFP-FlagSmad3 (Liu et al., 1997
)
was subcloned into the BglII-NotI site of
pGEX-FlagSmad3. To generate pGEX-GFP-Smad3 and its deletion mutants,
the EcoRI-NotI fragments of pcDNA3-6myc-Smad3 and
its mutants were subcloned into the EcoRI-NotI
site of pGEX-6P-2-hGFP, which carries the S65A/Y145F humanized green
fluorescent protein (GFP) gene at the multicloning site (provided by
Dr. S. Kuroda, Institute of Scientific and Industrial Research, Osaka, Japan).
Bacterial Expression and Purification of Proteins
The GST fusion proteins were expressed in Escherichia
coli BL21(DE3) or BL21(DE3) carrying the pT-Trx plasmid (Yasukawa
et al., 1995
). To induce proteins, bacteria were grown at
37°C to a density of 0.7 (OD550), and then
cultured in LB medium with 0.1 mM
isopropyl-
-D-thiogalactopyranoside at 20°C
overnight. Cells were harvested and disrupted by sonication in a lysis
buffer (20 mM Tris-HCl, pH 7.4, 150 mM NaCl, 1 mM dithiothreitol
[DTT], 1 mM EDTA, 1 mM phenylmethylsulfonyl fluoride, and 1% Nonidet P-40). After centrifugation, the supernatant was incubated with glutathione-Sepharose (Amersham Pharmacia Biotech) at 4°C. GST-fusion proteins bound on beads were washed extensively with washing buffer (20 mM Tris-HCl pH 7.4 and 150 mM NaCl) and used for pull-down experiments.
For in vitro import assays and microinjection, where noted, the GST
moiety was cleaved by thrombin or precision protease according to the
manufacturer's (Amersham Pharmacia Biotech) protocols. The soluble
protein passed through a PD10 column (Amersham Pharmacia Biotech)
equilibrated with transport buffer (20 mM HEPES, pH 7.3, 110 mM
potassium acetate, 2 mM magnesium acetate, 5 mM sodium acetate, and 0.5 mM EGTA) containing 2 mM DTT and protease inhibitor mixture, followed
by concentration by Centricon 30 or Centricon 50 (Amicon, Beverly, MA).
All primary protein species were detectable without significant
degradation products as determined by SDS-PAGE (not shown).
Expression and purification of mouse importin
(PTAC 97) was
performed as described (Kose et al., 1997
), as were the
purification of GST-mouse importin
(GST-PTAC 58) and GST-importin
(GST-PTAC 97) (Imamoto et al., 1995
). Recombinant human
p10/NTF2 protein was expressed and purified as described (Tachibana
et al., 1996
). Recombinant wild-type Ran and RanQ69L were
expressed, purified, and charged with GDP or GTP, respectively, as
described previously (Hieda et al., 1999
). The GST-NLS-GFP
fusion protein was expressed and purified to homogeneity using
glutathione-Sepharose as described previously (Nagoshi et
al., 1999
). Aliquots of each recombinant protein were frozen in
liquid nitrogen and stored at
80°C.
Cell Culture, Transient Transfections, and Viral Infections
Mink lung cells CCL64, the human colorectal cancer cell line
SW480.7 cells, and human embryonic kidney 293T cells were cultured in
DMEM supplemented with 10% FBS, L-glutamine, and
penicillin/streptomycin at 37°C, in a 5% CO2
atmosphere. HeLa cells were cultured in the same medium but
supplemented with 5% FBS. Transient transfections of 293T cells were
performed as described (Morén et al., 2000
; Pardali
et al., 2000
). Transient adenoviral infections of SW480.7 cells or CCL64 cells were performed as described (Piek et
al., 1999
; Pardali et al., 2000
). In brief, cells
seeded at a density of 1 × 106 in 100-mm
dishes were infected the next day with the appropriate adenovirus and
cultured for 48 h. The following day cells were washed and fed
fresh DMEM containing 10% FBS, and then treated with or without 10 ng/ml TGF-
1 for 1 h, and total cell lysates were prepared.
In Vitro Import Assays in Digitonin-permeabilized Cells
Transport assays were performed essentially as described (Adam
et al., 1990
; Imamoto et al., 1995
). Briefly,
1 × 105 HeLa cells/ml were plated on an
eight-well multitest slide (ICN, Costa Mesa, CA) 24-48 h before use.
Cells were rinsed twice with transport buffer and permeabilized for 5 min in ice-cold transport buffer containing 2 mM DTT, protease
inhibitor mixture, and 40 µg/ml digitonin. After washing twice the
slides were immersed in transport buffer containing 2 mM DTT and
protease inhibitor mixture at room temperature for 6 min. Excess buffer
was removed and cells were incubated with 10 µl/well of reaction
mixture for 12 min at room temperature (25-26°C). All reactions
contained an ATP regeneration system (1 mM ATP, 5 mM creatine
phosphate, and 20 U/ml creatine phosphokinase; Sigma), 2% bovine serum
albumin, 2 mM DTT, and protease inhibitor mixture in transport buffer. For in vitro import assays in the absence of ATP, 1.8 U/ml hexokinase (Toyobo, Osaka, Japan) and 5 mM glucose were added to the reaction mixture in the absence of the ATP regeneration system. For wheat germ
agglutinin (WGA) treatment, permeabilized cells were incubated with 0.5 mg/ml WGA (E.Y. Laboratories, San Mateo, CA) in transport buffer
containing 2 mM DTT and protease inhibitors for 5 min on ice before the
import reaction. For import assays in the presence of cytosol, Ehrlich
ascites tumor cell total cytosol was prepared as described (Imamoto
et al., 1995
). For import reconstitution assays, 0.4 µM
importin-
1, 1 µM p10, and 3 µM Ran-GDP or 3 µM RanQ69L-GTP
were used with 0.5 µM cargo proteins. After incubation, the cells
were rinsed with transport buffer and fixed with 3.7% formaldehyde in
transport buffer for 15 min at room temperature. After rinsing with
transport buffer, GFP-fusion proteins were detected by autofluorescence
microscopy. To examine the import of FlagSmad3D, fixed cells were
permeabilized with 0.5% Triton X-100 in transport buffer for 5 min at
room temperature, blocked with 3% skim milk for 30 min, and then
subjected to indirect immunofluorescence using a monoclonal anti-FLAG
M2 antibody as the first antibody and Cy3-labeled goat anti-mouse IgG
as secondary antibody. All photomicrographs were obtained in a Zeiss
Axioplan microscope equipped with a Hammamatsu digital camera.
In Vivo Import Assays in Microinjected Cells
For microinjection of recombinant Flag-tagged Smad proteins,
1 × 105 SW480.7 or HeLa cells were plated
on coverslips in 35-mm tissue culture dishes. The next day, the medium
was changed to normal medium containing 50 mM HEPES (pH 7.3), and
cultured for 3 h. Flag-Smad3 (3 mg/ml), Flag-Smad3D (1 mg/ml),
GFPSmad3 (1 mg/ml), or GFPSmad3MH1 (1 mg/ml) protein was injected
through a glass capillary into the cytoplasm by using an Eppendorf
(model 5246) automatic microinjector, and the cells were cultured for
1 h in normal medium. In the case of Flag-Smad3, cells were
cultured with or without 10 ng/ml TGF-
1 for 1 h. GFP-tagged
Smad proteins were microscopically detected after cell fixation with
3.7% formaldehyde in phosphate-buffered saline. Flag-tagged Smad
proteins were detected by indirect immunofluorescence as described
above. To observe the effect of dominant negative Ran on the nuclear
import of Smad3, cells were treated as described above and the control
protein GSTNLSGFP with or without RanQ69L-GTP was injected into the
cytoplasm, and the cells were analyzed as described above.
GST Protein Interaction Assays
Interaction assays of GST-importin
1 with nontagged,
6myc-tagged, and chimeric Smad proteins expressed in 293T cells were performed as described (Pardali et al., 2000
). For
interaction assays of GST-importins with adenovirally expressed
Flag-Smad3 proteins, SW480.7 or CCL64 cells were infected as described
above and GST pull-down assays of cell extracts were performed as
described (Sekimoto et al., 1997
).
Dissociation assays of GST-importin-
1 with Flag-Smad3D or
maltose-binding protein (MBP)-importin-
-binding domain (IBB) were performed by incubating 3 or 15 µg of the latter two purified proteins, respectively, with 25 µg of GST-importin-
1 at 4°C for 2 h followed by glutathione-Sepharose bead incubation for 1 h and extensive washing with transport buffer. Then, 10 µM of purified Ran-GDP or RanQ69L-GTP were added to the bound complexes followed by
incubation at 4°C for 1 h, centrifugation, and SDS-PAGE analysis of the obtained pellet and supernatant. Proteins were detected by
Coomassie Brilliant Blue staining and quantified densitometrically using a luminescent image analyzer LAS-1000plus and the integrated advanced image data analyzer (Fuji Photo Film, Stockholm, Sweden).
Interaction assays of baculoviral 6-his-Smad3 or
receptor-phosphorylated 6-his-Smad3 (6-his-Smad3-P) with
GST-importin-
1 were performed by mixing 2.5 µg of pure Smad
proteins with COS-7 total cell lysate prepared as previously described
(Sekimoto et al., 1997
), and diluted in transport buffer to
simulate nuclear transport conditions. The protein-cell extract
mixture was precleared with Sepharose beads at 4°C for 30 min, and
then 1 nmol of GST or GST-importin-
1 was added and incubation
continued at 4°C for 2 h, followed by exhaustive washing with
transport buffer and SDS-PAGE analysis. Smad proteins were detected by
immunoblotting with penta-histidine antibody and the
phosphorylation status of the 6-his-Smad3-P preparation was verified by
anti-phosphoserine antibody blotting.
| |
RESULTS |
|---|
|
|
|---|
Establishment of In Vitro and In Vivo Nuclear Import Assays Point to an Active Transport Mechanism for Smad3
An in vitro Smad3 import assay was developed using the established
digitonin-permeabilized HeLa cell-free transport system (Figure
1) (Adam et al., 1990
).
In this system and in many other TGF-
-responsive or not responsive
cell lines, permeabilization led to quantitative loss of all cellular
Smad3 (our unpublished results). As a source of exogenous Smad3
protein, N terminally Flag-tagged Smad3 was isolated from E. coli as a GST-fusion that was subsequently cleaved with thrombin
and purified (Figure 1A, lane 1). To obtain activated Smad3 in the in
vitro import assay (where the signaling pathway is disrupted by
digitonin treatment), we used a triple point mutant of Smad3, Smad3D,
in which the three carboxyl terminal serine residues of the SSXS motif
are mutated to aspartate residues. The substitution of these serine
residues to negatively charged residues has been shown to mimic
phosphorylation by receptor and results in constitutive activation of
the protein (Liu et al., 1997
). The Smad3D protein was also
purified from E. coli (Figure 1A, lane 2).
|
The functional integrity of the recombinant Smad3 proteins was tested
by microinjection into the cytoplasm of live human colon carcinoma
SW480.7 cells together with a control GSTNLSGFP protein that contains
the potent simian virus 40 virus large T antigen NLS fused between the
GST and GFP moieties (Figure 1B). To obtain ligand-stimulated
conditions the cells were transiently infected with an adenovirus
expressing the constitutively active (ca) type I receptor of TGF-
(activin receptor-like kinase [ALK]-5) and treated with extracellular
TGF-
1 to achieve maximal level of Smad activation and nuclear
translocation. The corresponding nonstimulated condition was obtained
by transiently infecting cells with an adenovirus expressing the LacZ
gene and treatment with vehicle. The results demonstrate that the
recombinant Smad3 behaved physiologically, because it exhibited diffuse
cytoplasmic distribution in the absence of stimulation and translocated
quantitatively to the nucleus after stimulation with TGF-
1 (Figure
1B). Smad3D localized in the nucleus in the absence or presence of
stimulation (our unpublished results). As expected, the coinjected
control GSTNLSGFP protein constitutively localized to the nuclei of the
microinjected cells and its distribution was not affected by activation
of TGF-
receptors.
In vitro import assays in the absence of added cytosol followed by
anti-Flag immunofluorescence revealed that Smad3 accumulated around the
nuclear envelope (Figure 1C). When cytosol was added, the concentrated
perinuclear staining was replaced by a weak and diffuse nuclear
staining of Smad3, suggesting inefficient nuclear import (Figure 1C).
Thus, Smad3 that has not been activated by TGF-
receptors cannot
accumulate efficiently in the nucleus as expected. When Smad3D was
tested, it exhibited ring-like perinuclear staining like Smad3 in the
absence of cytosol (Figure 1C). In contrast to wild-type Smad3, Smad3D
efficiently entered the nucleus when cytosol was added (Figure 1C). The
behavior of Smad3D in this assay was identical to that of the positive
control, the GSTNLSGFP (Figure 1C). We conclude that Smad3 activated by
the TGF-
signal is transported to the nucleus by an active mechanism that requires cytosolic factors, as is the case for most other NLS-containing proteins.
Smad3 Interacts with Importin-
1 in a TGF-
Pathway-specific
Manner
The cytosol-dependent import of Smad3D suggests that carriers of
the importin-
family may be involved in activated Smad3 transport.
To test this hypothesis, we performed protein-protein interaction
assays (Figure 2A). We prepared total
cell extracts of SW480.7 or mink lung CCL64 cells transiently infected
with an adenovirus that expresses wild-type Smad3, after stimulation or
not with TGF-
1 and ca-ALK-5. These extracts were incubated with
GST-fusions of importin-
1 and -
2, bound proteins were isolated and analyzed by SDS-PAGE, and Smad3 was detected by anti-Flag immunoblotting (Figure 2A). Importin-
1 demonstrated
positive and specific interaction with Smad3, and only after
stimulation with TGF-
1 and/or ca-ALK-5. Less efficient association
was obtained when cells were either treated with TGF-
1 alone or
infected with ca-ALK-5 alone (our unpublished results). The control GST
protein did not interact. We also tested whether adaptors of the
importin-
family can interact with Smad3. For this, we repeated the
GST-interaction assays using GST-importin-
1, -
2, and -
3
(Figure 2B). None of these proteins showed any specific interaction
with Smad3.
|
To further analyze the specificity of the Smad3-importin-
1
interaction, we used similar cell extracts that contained in addition to Smad3 and ca-ALK-5, the inhibitory Smad7 that blocks R-Smad phosphorylation and activation by the type I receptor (Figure 2C) (ten
Dijke et al., 2000
). Whereas activated and phosphorylated Smad3 avidly bound to importin-
1, Smad7 efficiently blocked the Smad3-importin-
1 interaction, confirming that this protein complex forms only when the signaling pathway is activated. Probing for phosphorylated Smad3 in these experiments, we demonstrated that Smad7
inhibited Smad3 phosphorylation by receptor, thus resulting in weak
Smad3 association with importin-
1 (Figure 2C). As a negative control, we tested the Smad3-importin-
1 association under
conditions where the cells were stimulated with another TGF-
superfamily member, BMP-7, and the constitutively active BMP type IB
receptor (ca-ALK-6). This treatment, which results in Smad1, Smad5, and Smad8 activation (our unpublished results), but not Smad3 activation, failed to induce Smad3 phosphorylation or Smad3-importin-
1
association, as expected (Figure 2C).
Finally, to confirm that the strict ligand dependency of the
Smad3-importin-
1 association depends on the C-terminal SSXS phosphorylation status, we performed interaction assays with 1) histidine (his)-tagged Smad3 (S3) purified from baculovirus-infected insect cells, or with 2) C terminally phosphorylated Smad3 (S3P) that
was produced in insect cells coinfected with Smad3 and ca-ALK-5 receptor (Figure 2D) (Johnson et al., 1999
). Whereas
nonphosphorylated Smad3 interacted weakly with importin-
1,
phospho-Smad3 reproducibly exhibited significantly stronger
interaction. Control GST could not support any specific association
with the Smad proteins used, and control immunoblot
analysis with anti-histidine and anti-phospho-serine antibodies
verified the levels and fidelity of phosphorylation of the baculoviral
Smad3 preparations (Figure 2D). We therefore conclude that Smad3, after
phosphorylation by the TGF-
type I receptor, can specifically
interact with importin-
1 but not with importin-
adaptors. The
same conclusion has been recently reported by another group (Xiao
et al., 2000b
).
Dominant Negative Mutant RanQ69L-GTP Quantitatively Inhibits the
TGF-
and Receptor-activated Import of Smad3 into the Nucleus
If importin-
1 indeed mediates nuclear transport
of activated Smad3, then the Ran GTPase could possibly regulate this
process. To test this hypothesis we performed in vivo experiments in
SW480.7 cells whose cytoplasm was microinjected with the internal
control GSTNLSGFP protein together with bacterially purified
dominant negative RanQ69L-GTP (which binds GTP strongly but cannot
hydrolyze it) (Görlich and Kutay, 1999
). To monitor Smad3, the
same cells were infected with the Smad3 adenovirus before
microinjection and were treated or not with TGF-
1 for 1 h
before immunostaining (Figure 3A).
Control uninjected cells demonstrated the correct ligand-dependent
translocation of Smad3 to the nucleus (top panels) confirming that the
conditions of adenoviral infection preserve the physiological behavior
of the signaling pathway as previously described (Piek et
al., 1999
). When GSTNLSGFP plus buffer alone were microinjected
into the infected cells, Smad3 exhibited the same normal localization
as in the uninjected controls, demonstrating that the microinjection
process also preserves the physiology of the signaling pathway (middle
panels). Under these conditions, GSTNLSGFP showed constitutive nuclear
accumulation and treatment with TGF-
1 did not alter the nuclear
transport of GSTNLSGFP, as expected. Finally, microinjection of
RanQ69L-GTP into the cytoplasm of the infected cells resulted in the
expected inhibition of the control GSTNLSGFP in both untreated cells
and in cells treated with TGF-
1 (bottom panels). RanQ69L-GTP
potently inhibited the nuclear translocation of Smad3 in the
TGF-
1-stimulated cells and led to partial nuclear accumulation of
Smad3 in nonstimulated cells. These experiments demonstrate that the
Ran GTPase regulates the active process of Smad3 import after
stimulation with ligand. They also raise the possibility that Smad3 is
localized to the cytoplasm of unstimulated cells due to an active
export mechanism (see DISCUSSION).
|
To biochemically link the action of the dominant negative Ran with the
observed Smad3-importin-
1 complexes, we attempted to dissociate
Smad3 from the in vitro complex with importin-
1 (Figure 3B).
Incubation of the Smad3D-importin-
1 complex with Ran-GDP primarily
resulted in retention of the complex on the glutathione-Sepharose
column via the immobilized GST-importin-
1. Under these conditions
only 2.5% of Smad3D dissociated from the column. However, incubation
of the immobilized importin-
1-Smad3D complex with recombinant
RanQ69L-GTP resulted in measurable elution (21.5%) of Smad3D (Figure
3B). As a positive control, a similar experiment was performed with a
complex of importin-
1 and the domain of importin-
that
specifically binds to importin-
1 (IBB) (Görlich and Kutay,
1999
). These two proteins also formed a strong complex that resulted in
only 1.7% elution after incubation with Ran-GDP but was partially
dissociated (21%) by RanQ69L-GTP. The dissociation profiles of IBB and
Smad3D are similar, suggesting that binding of Ran-GTP to importin-
1
induces dissociation of the importin-
1-Smad3D complex as it does
for the IBB fragment. Thus, upon stimulation with TGF-
, Smad3 is
imported into the nucleus by importin-
1, after which Ran mediates
Smad3 release from the importin complex.
MH1 Domain of Smad3 but not Smad2 Interacts Directly with
Importin-
1
We then dissected the domain of Smad3 that is required for
interaction with importin-
1 and nuclear import (Figure
4A). Using a panel of Smad3 deletion
mutants transiently overexpressed in 293T cells, which were stimulated
with TGF-
1, we performed in vitro interaction assays by passing
extracts from the transfected cells over the GST-importin-
1 column
or a GST column as negative control. The bound Smad3 proteins were
detected via their N-terminal 6-myc tag by
immunoblotting analysis (Figure 4B). Full-length Smad3,
the MH1-linker, and the MH1 domains all specifically bound to the
importin-
1 affinity column. In contrast, the linker-MH2, the linker,
and the MH2 domains did not associate with importin-
1. Interestingly
deletion of the MH2 domain resulted in relative enhancement of Smad3
interaction with importin-
1 compared with the full-length protein.
Further deletion of the linker domain, leaving only the isolated MH1
domain, enhanced the interaction even more (Figure 4B). This is not due
to differential protein expression of the various Smad3 domains (Figure
4D). As a negative control, the interaction of the Smad3 mutants with
GST was tested and no specific associations were detected (Figure 4C).
We conclude that the MH1 domain of Smad3 is the primary determinant for
the specific association with importin-
1 and that this
interaction requires conformational exposure of the MH1 domain that is
induced by receptor phosphorylation, negatively charged amino acid
substitution in the SSXS motif (Smad3D), or C-terminal truncation.
|
In contrast, a recent report demonstrated the role of the MH2 domain on
the cytosolic factor-independent import mechanism of Smad2 (Xu et
al., 2000
). On the other hand, another group emphasized the
importance of an NLS-like sequence in the MH1 domain of Smad3 for
nuclear import and interaction with importin-
1, in agreement with
the above-described data (Xiao et al., 2000a
,b
). This
NLS-like motif is identical in both Smad2 and Smad3. To resolve the
question of possible differences between the two related R-Smads of the TGF-
/activin pathways, we focused on the strength of interaction between Smads and importin-
1 as a measure of specificity of nuclear import mechanism. Smad2 and Smad3 are highly related in primary amino
acid sequence (Heldin et al., 1997
). However, the MH1 domain of Smad2 contains two inserts that are specifically absent from Smad3
and have been termed GAG and TID based on the central amino acid
triplet of each insert (Dennler et al., 1999
). These two inserts localize on either side of the lysine-rich NLS-like motif of
Smad2 (Shi et al., 1998
). Insert TID has been shown to
render Smad2 unable to recognize the Smad binding element on DNA,
whereas an alternatively spliced form of Smad2 that specifically lacks the insert TID binds to DNA as efficiently as Smad3 (Dennler et al., 1999
; Yagi et al., 1999
). We therefore focused on
the importance of these inserts by analyzing a series of chimeras
between the MH1 domains of Smad2 and Smad3 (Figure 4E). Using the same
293T overexpression protocol followed by GST-importin-
1 pull-down assay described in Figure 4A, we demonstrated that Smad2 cannot associate with importin-
1 in the absence or presence of stimulation by TGF-
1 (Figure 4F). The chimera that lacks both MH1 inserts (Smad2-
GAG-
TID) exhibited weak constitutive association with importin-
1 that was strongly enhanced by treatment with TGF-
1, thus resembling partially Smad3 (Figure 4F). The critical sequence affecting the association with importin-
1 maps to the insert TID
because removal of this insert only makes Smad2 capable of interaction
in a ligand-dependent manner, like Smad3, whereas removal of the insert
GAG had no effect compared with wild-type Smad2 (Figure 4F). It must be
noted that the chimeric proteins contain a small number of amino acid
substitutions in the nondeleted portions of the MH1 domain, most of
which are conservative and thus are not expected to contribute
significantly to the observed associations with importin-
1. Using
the same assay we observed that addition of an N-terminal epitope tag
on Smad2 also resulted in efficient association of Smad2 with
importin-
1 (our unpublished results). We conclude that Smad2 and
Smad3 indeed differ in their capacity to associate with importin-
1
and this specificity is defined by the unique Smad2 insert TID encoded
by exon 3. Thus, the mechanisms of nuclear import of these two related
Smads rely on different components that must be dictated by the
differential folded structures of their activated MH1 and MH2 domains.
The fully conserved NLS-like motif may be important but is not the primary determinant of specificity.
MH1 Domain Mimics Signal-dependent Wild-Type Smad3 Import, and the MH2 Domain Exhibits Only Weak Constitutive Import Activity
To examine the role of the various Smad3 domains in nuclear import
we performed in vitro import assays in permeabilized HeLa cells by
using a panel of Smad3 deletion mutants whose N termini were now fused
to GFP to facilitate detection (Figure
5). The deletion mutants were
compared with Smad3D, which was also fused N terminally to GFP.
GSTNLSGFP served as the positive control. As anticipated, GFP-Smad3D
exhibited cytosol-dependent nuclear import, confirming the data of
Figure 1C. GFP-Smad3MH1 showed a perinuclear ring in the absence of
cytosol and strong nuclear accumulation in the presence of cytosol. The
cytosol-dependent import of Smad3D and Smad3 MH1 in vitro was
blocked 1) when ATP was depleted from the cytosol by the addition of
hexokinase and glucose; 2) when the permeabilized cells were pretreated
with the lectin WGA, which binds to the cytoplasmic sugars of the
nuclear pore complex; or 3) when the system was incubated on ice
(Figure 5). All such blocking treatments resulted in the perinuclear, ring-like accumulation of the exogenous Smads. GFP-Smad3Linker (L)
performed rather inefficiently in in vitro import assays, exhibiting
both weak constitutive and cytosol-enhanced import activity (Figure 5).
GFP-Smad3MH2 showed weak but distinct nuclear localization in the
absence of cytosol (our unpublished results). The efficiency of
constitutive and cytosol-independent nuclear import of the Smad3 MH2
domain was under all conditions tested much lower than the efficiency
of cytosol-dependent import of the full length or MH1 domain of Smad3.
A second chimera encoding GSTGFP-Smad3MH2, which is substantially
larger than the GFP-Smad3MH2 fusion protein, exhibited almost no
nuclear import under all conditions tested (Figure 5). The
cytosol-dependent and energy-dependent import of the GSTNLSGFP control
also confirms the quality and fidelity of the digitonin-permeabilized
HeLa cell system. We conclude that the MH1 domain specifies the active
nuclear import of Smad3. However, in certain fusion constructs, the
nuclear import activity of the Smad3 MH2 domain resembles the
constitutive import function of the Smad2 MH2 domain described recently
(Xu et al., 2000
).
|
In Vitro Reconstitution of Smad3 Import by Importin-
1, p10/NTF2,
and Ran
To demonstrate that the nuclear transport components importin-
1
and Ran are sufficient for Smad3 nuclear transport, we designed reconstitution experiments of in vitro import by using only purified proteins as reaction components. As demonstrated in Figure
6, importin-
1 alone was capable of
only limited nuclear import of Smad3D. Ran-GDP in the presence of its
nuclear carrier p10/NTF2 showed no nuclear translocation. Finally,
combination of importin-
1 and Ran-GDP plus p10/NTF2 gave strong
nuclear accumulation, to the same level as that seen when cytosol was
added. Importantly, replacement of Ran-GDP with RanQ69L-GTP led to
perinuclear accumulation and complete blockade of Smad3D import. The
same results were obtained when the GFP-MH1 protein was used as cargo
(Figure 6). The results demonstrate that importin-
1 and Ran, in
association with p10/NTF2, are all the components required to mediate
the active nuclear import of phosphorylated Smad3, or an isolated MH1
domain.
|
| |
DISCUSSION |
|---|
|
|
|---|
Active Nuclear Import of the Receptor-activated Smad3
The in vitro import assay developed for Smad3 in digitonin-permeabilized HeLa cells enabled us to demonstrate that receptor-activated Smad3, represented by the point mutant Smad3D, is transported into the nucleus in an active manner that requires soluble cytosolic factors and metabolic energy (Figures 1 and 5). By contrast, nonactivated Smad3 protein is inefficiently retained in the nuclei of permeabilized cells, suggesting a slow rate of constitutive import in the presence of cytosolic factors.
The fundamental difference between nonactivated and activated Smad3 is
consistent with the previously proposed model of Smad autoinhibition,
whereby the intramolecular interaction of the MH1 and MH2 domains
results in cytoplasmic retention and inactivity (Hata et
al., 1997
). Smad cytoplasmic retention could possibly involve the
specific membrane anchor of Smads, SARA, the receptor-associated scaffold protein ARIP, and/or microtubules (Tsukazaki et
al., 1998
; Dong et al., 2000
; Shoji et
al., 2000
). We propose that in addition to release from
autoinhibition, C-terminal serine phosphorylation by the type I
receptor kinase must result in specific conformational changes that
modify the structure of the MH1 domain (Shi et al., 1997
,
1998
; Qin et al., 1999
), resulting in exposure of the
importin-
1-associating interface. These predictions also deserve
further biochemical and biophysical experimentation.
Smad3 MH1 Domain and Importin-
1 Define the Specificity of Smad3
Import
The active import of receptor-activated Smad3 could be explained
by a classic transport pathway involving the adaptor importin-
as a
cargo-interacting component and importin-
as the carrier mediating
shuttling through the nuclear pore (Görlich and Kutay, 1999
).
However, the screen we performed for various importin members that
could specifically interact with Smad3 scored positively only for
importin-
1 (Figure 2). Thus, Smad3 is capable of direct interaction
with the major carrier component and does not require the adaptor
importin-
. In this sense Smad3 joins a growing list of proteins
whose regulated nuclear import is mediated solely by importin-
. Such
proteins include cyclin B1, the retroviral Tat, Rev, and Rex proteins,
sterol-regulated element binding protein-2, insulin-like growth factor
binding protein-3 and -5, and more (Moore et al., 1999
;
Nagoshi et al., 1999
; Palmeri and Malim, 1999
; Takizawa
et al., 1999
; Truant and Cullen, 1999
; Schedlich et
al., 2000
). Shuttling through the nuclear pore occurs by a series
of association-dissociation events of the importin-cargo complex to
nucleoporins (Görlich and Kutay, 1999
; Allen et al., 2000
; Rout et al., 2000
). Our preliminary evidence suggests
that the Smad3-importin-
1 complex can associate with nucleoporins containing phenylalanine-glycine repeats (Kurisaki and Moustakas, unpublished observations).
The specificity assays of Figure 2C further support the evidence that
the importin-
1-Smad3 association, and by extension, Smad3 import,
depend on an active TGF-
signaling pathway that cannot be
phenocopied by overexpression of a related but distinct signaling
pathway such as the BMP pathway. In addition, Smad7 was shown to
efficiently block the TGF-
-induced Smad3 phosphorylation and
association with importin-
1, presumably due to Smad7's ability to
block the kinase activity of the type I receptor (Hayashi et al., 1997
; Nakao et al., 1997
).
The Smad3 structural determinant(s) required for the interaction with
importin-
1 mapped to the N-terminal conserved MH1 domain (Figure 4).
Furthermore, the isolated MH1 domain exhibited cytosol- and
energy-dependent import that was similar to full-length Smad3, but
independent from activation by ligand (Figure 5). This is in contrast
to the other two domains, the linker and MH2, of Smad3. We postulate
that the MH1 domain must include specific structural determinants that
mediate the importin-
1 interaction and efficient Smad3 import. The
short motif, K40KLKK44,
which is part of a relatively unexposed-to-solvent
-helix, as
proposed by the Smad3 MH1-DNA complex structure, is conserved in all
the R-Smads, the CoSmads Smad4 and 4
, and the inhibitory Smad7 (Shi
et al., 1998
; Masuyama et al., 1999
). Consistent
with our findings, Xiao et al. (2000a
,b
) recently reported
that this specific Smad3 sequence indeed functions as a true NLS and
mediates interaction with importin-
1. However, our analysis of
Smad2-importin-
1 interaction (Figure 4B) demonstrated that
additional structural determinants in the MH1 domain regulate the
specificity of this association. Thus, it is possible that a higher
order structure is the specific structural determinant of the
Smad3-importin-
1 interface and the defined NLS sequence may be
important but not the only critical determinant.
The Smad3 MH2 domain in certain fusion constructs was found to
spontaneously and partially accumulate in the nuclei of permeabilized cells in the absence of cytosol (our unpublished results), whereas in
other constructs not (Figure 5). It is possible that the MH2 domain may
exhibit weak but significant affinity for nucleoporins and thus enters
the nucleus constitutively. Constitutive but strong nuclear
accumulation of the isolated MH2 domain of Smad2 was recently reported
and this finding led to a model whereby Smad2 nuclear import is
receptor phosphorylation-independent, cytosol-independent but
energy-dependent and mediated by the MH2 domain (Xu et al., 2000
). Although our in vitro import data for the Smad3 MH2 domain partially agree with the Smad2 model, both in vitro and in vivo import
experiments of full-length Smad3 point to the distinct nuclear import
mechanisms of these two related Smads. This suggested to us that the
mechanism of Smad2 import might differ from that of Smad3, despite the
conservation of the putative MH1 NLS motif. In agreement with this
hypothesis we demonstrated that Smad2 could not interact with
importin-
1 due to a unique sequence insert termed TID in its MH1
domain (Figure 4B). Interestingly, the same sequence determinant also
results in Smad2's inefficient binding to the Smad binding element
(Dennler et al., 1999
; Yagi et al., 1999
). Thus,
two important functions, nuclear import and DNA binding are coregulated
by the same structural motifs in the MH1 domain of Smad2. These results
allow us to postulate that in Smad2, importin-mediated nuclear import
is deficient and thus the intrinsic import activity of the MH2 domain
prevails as recently described (Xu et al., 2000
). In
addition, our findings predict that the alternatively spliced form of
Smad2 that lacks exon 3 could associate with importin-
1 and thus be
imported by a different mechanism than Smad2.
Ran-dependence of Smad3 Import
Both our in vitro and in vivo import approaches establish a
requirement for the small GTPase Ran in the regulation of Smad3 nuclear
import (Figures 3 and 6). Ran-GTP is important at the nuclear face of
the pore for release of the cargo protein to the nucleoplasm
(Görlich and Kutay, 1999
). This is achieved by the specific
interaction of Ran-GTP with importin-
. In agreement with this
mechanism, we demonstrate that the mutant RanQ69L-GTP, which is
constitutively locked in the GTP form and thus mimics endogenous
Ran-GTP, can cause dissociation of Smad3D from the importin-
1
complex under in vitro conditions (Figure 3B). Thus, when RanQ69L-GTP
is injected into the cytoplasm, it inhibits binding of importin-
1 to
activated Smad3 and so inhibits Smad3 nuclear import (Figure 3A).
Consistent with this notion, in the in vitro reconstitution system
where only purified components are added, RanQ69L-GTP efficiently
blocked the import of Smad3D (Figure 6). This result proves that the
mechanism of regulation of Smad3 import by Ran operates at the level of
Smad3-importin-
1 complex dissociation. The efficient inhibition of
TGF-
-stimulated Smad3 nuclear import by RanQ69L-GTP in the
microinjection experiments supports the notion that the dominant import
pathway for Smad3 is Ran-dependent. Therefore, a cytosolic
factor-independent nuclear import pathway mediated by the MH2 domain
may be a minor route for Smad3 translocation to the nucleus.
An unexpected result was that RanQ69L-GTP microinjection in live cells
consistently resulted in partial nuclear accumulation of Smad3 in the
nonligand-stimulated state (Figure 3A). This can be interpreted by
RanQ69L-GTP squelching the available cytosolic importin-
1, thus
enhancing the weak constitutive import activity of Smad3 driven by its
MH2 domain. Alternatively, because the Ran GTPase is involved in active
nuclear export of macromolecules (Mattaj and Englmeier, 1998
; Yoneda
et al., 1999
), we propose that nuclear accumulation of Smad3
under these conditions can also be explained by a change in the Ran-GTP
equilibrium across the nuclear pore, which leads to nuclear
accumulation of the exported cargo, as previously demonstrated (Nachury
and Weis, 1999
).
Generalization of the Import Mechanism for Smad Proteins
This report describes a nuclear transport pathway for a member of
the Smad family of tumor suppressors. The import process is active and
regulated by Ran and thus guarantees rapid, efficient, and regulated
nuclear import. In this report we have focused on a single Smad, Smad3,
to develop useful import assays for this family of proteins. However,
this report and those recently describing the Smad3 NLS and the Smad2
import mechanism (Xiao et al., 2000a
,b
; Xu et
al., 2000
) pose the question of how general is the import mechanism of Smad proteins. In contrast to the previous reports we
provide evidence that the two related Smads of the TGF-
/activin pathways are imported via distinct mechanisms due to the differential ability of their MH1 domains to interact with importin-
1, which possibly leads to a differential utilization of the constitutive nuclear import function of their MH2 domains. Thus, we propose that the
nuclear import mechanisms of all other family members deserves further
experimentation and cannot be safely extrapolated by the findings on a
single Smad protein. It is also of interest to examine whether other
Smad members, including Smad2, are imported to the nucleus in response
to ligand and receptor activation by a Ran-dependent mechanism.
Finally, Smad2, Smad3, and Smad4 have been proposed to translocate as a
single oligomeric complex (Heldin et al., 1997
). The import
mechanism for such a complex must be characterized to define whether it
behaves like any of its components or independently. Thus, the paradigm
of Smad3 nuclear import established here offers an important reference
point for future investigations of the mechanisms of Smad protein
nucleo-cytoplasmic shuttling.
| |
ACKNOWLEDGMENTS |
|---|
We are grateful to N. Ferrara and K. Sampath for providing
TGF-
1 and BMP-7, respectively, and to G. Blobel, J.-M. Gauthier, D. Görlich, S. Itoh, S. Kuroda, X. Liu, H. F. Lodish, P. ten Dijke, and N. Yaseen for various bacterial and mammalian expression plasmids. We thank K. Miyazono for the adenoviral stocks, M. F. Hoffman, and A. Comer for the baculoviral 6-his-Smad3 proteins, and
D.O. Morgan for advice and a thorough review of this manuscript. This
research was partly supported by grants from the Human Frontier Science
Program (to A.M. and Y.Y.). A.K. is recipient of a postdoctoral fellowship from the Swedish Foundation for International Cooperation in
Research and High Education.
| |
FOOTNOTES |
|---|
Corresponding author. E-mail
address: aris.moustakas{at}licr.uu.se.
| |
REFERENCES |
|---|
|
|
|---|
activity.
Mol. Cell
5, 27-34[Medline].
receptor and functions as an antagonist of TGF
signaling.
Cell
89, 1165-1173[Medline].
" § 12 signaling from cell membrane to nucleus through SMAD proteins.
Nature
390, 465-471[Medline].
-induced phosphorylation of Smad3 is required for growth inhibition and transcriptional induction in epithelial cells.
Proc. Natl. Acad. Sci. USA
94, 10669-10674
signaling in growth control, cancer, and heritable disorders.
Cell
103, 295-309[Medline].
signaling.
Genes Dev.
14, 627-644
/Smad signaling system.
EMBO J.
19, 1745-1754[Medline].
-inducible antagonist of TGFf-
" § 12 signaling.
Nature
389, 631-635[Medline].
can mediate the nuclear import of an arginine-rich nuclear localization signal in the absence of importin
.
Mol. Cell. Biol.
19, 1218-1225
.
J. Biol. Chem.
275, 29244-29256
type I receptor/ALK-5 and Smad proteins mediate epithelial to mesenchymal transdifferentiation in NMuMG breast epithelial cells.
J. Cell Sci.
122, 4557-4568.
s. In: Peptide Growth Factors and Their Receptors, ed. M.B. Sporn, and
A.B. Roberts, Heidelberg, Germany: Springer Verlag, 419-472.
subunit.
J. Biol. Chem.
275, 23462-23470
signaling.
Cell
94, 585-594[Medline].
.
Proc. Natl. Acad. Sci. USA
96, 7938-7943
signaling.
Trends Biochem. Sci.
25, 64-70[Medline].
-dependent nuclear localization signals.
Mol. Cell. Biol.
19, 1210-1217
receptor.
Cell
95, 779-791[Medline].
mediates nuclear translocation of Smad 3.
J. Biol. Chem.
275, 23425-23428
-dependent phosphorylation.
Nat. Cell Biol.
2, 559-562[Medline].This article has been cited by other articles:
![]() |
X. Yao, X. Chen, C. Cottonham, and L. Xu Preferential Utilization of Imp7/8 in Nuclear Import of Smads J. Biol. Chem., August 15, 2008; 283(33): 22867 - 22874. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Schmierer, A. L. Tournier, P. A. Bates, and C. S. Hill Mathematical modeling identifies Smad nucleocytoplasmic shuttling as a dynamic signal-interpreting system PNAS, May 6, 2008; 105(18): 6608 - 6613. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. R. Williamson and P. R. Hiesinger Synaptic Patterning by Morphogen Signaling Sci. Signal., May 6, 2008; 1(18): pe20 - pe20. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Minoo, L. Hu, N. Zhu, Z. Borok, S. Bellusci, J. Groffen, D. Kardassis, and C. Li SMAD3 prevents binding of NKX2.1 and FOXA1 to the SpB promoter through its MH1 and MH2 domains Nucleic Acids Res., January 17, 2008; 36(1): 179 - 188. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Saka, A. I. Hagemann, O. Piepenburg, and J. C. Smith Nuclear accumulation of Smad complexes occurs only after the midblastula transition in Xenopus Development, December 1, 2007; 134(23): 4209 - 4218. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Xu, X. Yao, X. Chen, P. Lu, B. Zhang, and Y. T. Ip Msk is required for nuclear import of TGF-{beta}/BMP-activated Smads J. Cell Biol., September 7, 2007; 178(6): 981 - 994. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. H. Youn and J.-S. Shin Nucleocytoplasmic Shuttling of HMGB1 Is Regulated by Phosphorylation That Redirects It toward Secretion J. Immunol., December 1, 2006; 177(11): 7889 - 7897. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Banh, P. A. Deschamps, J. Gauldie, P. A. Overbeek, J. G. Sivak, and J. A. West-Mays Lens-Specific Expression of TGF-{beta} Induces Anterior Subcapsular Cataract Formation in the Absence of Smad3. Invest. Ophthalmol. Vis. Sci., August 1, 2006; 47(8): 3450 - 3460. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Luo, E. Nieves, J. Kzhyshkowska, and R. H. Angeletti Endogenous Transforming Growth Factor-{beta} Receptor-mediated Smad Signaling Complexes Analyzed by Mass Spectrometry Mol. Cell. Proteomics, July 1, 2006; 5(7): 1245 - 1260. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-G. Chen, Q. Wang, S.-L. Lin, C. D. Chang, J. Chung, and S.-Y. Ying Activin Signaling and Its Role in Regulation of Cell Proliferation, Apoptosis, and Carcinogenesis. Experimental Biology and Medicine, May 1, 2006; 231(5): 534 - 544. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Kurisaki, K. Kurisaki, M. Kowanetz, H. Sugino, Y. Yoneda, C.-H. Heldin, and A. Moustakas The Mechanism of Nuclear Export of Smad3 Involves Exportin 4 and Ran Mol. Cell. Biol., February 15, 2006; 26(4): 1318 - 1332. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Miyauchi, T. Michigami, N. Sakaguchi, T. Sekimoto, Y. Yoneda, J. W. Pike, M. Yamagata, and K. Ozono Importin 4 Is Responsible for Ligand-independent Nuclear Translocation of Vitamin D Receptor J. Biol. Chem., December 9, 2005; 280(49): 40901 - 40908. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Massague, J. Seoane, and D. Wotton Smad transcription factors Genes & Dev., December 1, 2005; 19(23): 2783 - 2810. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Schmierer and C. S. Hill Kinetic Analysis of Smad Nucleocytoplasmic Shuttling Reveals a Mechanism for Transforming Growth Factor {beta}-Dependent Nuclear Accumulation of Smads Mol. Cell. Biol., November 15, 2005; 25(22): 9845 - 9858. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Prokova, S. Mavridou, P. Papakosta, and D. Kardassis Characterization of a novel transcriptionally active domain in the transforming growth factor {beta}-regulated Smad3 protein Nucleic Acids Res., July 1, 2005; 33(12): 3708 - 3721. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. I. Suszko, D. M. Balkin, Y. Chen, and T. K. Woodruff Smad3 Mediates Activin-Induced Transcription of Follicle-Stimulating Hormone {beta}-Subunit Gene Mol. Endocrinol., July 1, 2005; 19(7): 1849 - 1858. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. B. Chen, J. G. Rud, K. Lin, and L. Xu Nuclear Targeting of Transforming Growth Factor-{beta}-activated Smad Complexes J. Biol. Chem., June 3, 2005; 280(22): 21329 - 21336. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Yamasaki, T. Sekimoto, T. Ohkubo, T. Douchi, Y. Nagata, M. Ozawa, and Y. Yoneda Zinc finger domain of Snail functions as a nuclear localization signal for importin {beta}-mediated nuclear import pathway Genes Cells, May 1, 2005; 10(5): 455 - 464. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Pan, L. D. Estevez-Salmeron, S. L. Stroschein, X. Zhu, J. He, S. Zhou, and K. Luo The Integral Inner Nuclear Membrane Protein MAN1 Physically Interacts with the R-Smad Proteins to Repress Signaling by the Transforming Growth Factor-{beta} Superfamily of Cytokines J. Biol. Chem., April 22, 2005; 280(16): 15992 - 16001. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Sakakida, Y. Miyamoto, E. Nagoshi, M. Akashi, T. J. Nakamura, T. Mamine, M. Kasahara, Y. Minami, Y. Yoneda, and T. Takumi Importin {alpha}/{beta} Mediates Nuclear Transport of a Mammalian Circadian Clock Component, mCRY2, Together with mPER2, through a Bipartite Nuclear Localization Signal J. Biol. Chem., April 8, 2005; 280(14): 13272 - 13278. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. R. Dunn, C. H. Koonce, D. C. Anderson, A. Islam, E. K. Bikoff, and E. J. Robertson Mice exclusively expressing the short isoform of Smad2 develop normally and are viable and fertile Genes & Dev., January 1, 2005; 19(1): 152 - 163. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.S. Prime, M. Pring, M. Davies, and I.C. Paterson TGF-{beta} SIGNAL TRANSDUCTION IN ORO-FACIAL HEALTH AND NON-MALIGNANT DISEASE (PART I) Critical Reviews in Oral Biology & Medicine, November 1, 2004; 15(6): 324 - 336. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. J. Nicolas, K. De Bosscher, B. Schmierer, and C. S. Hill Analysis of Smad nucleocytoplasmic shuttling in living cells J. Cell Sci., August 15, 2004; 117(18): 4113 - 4125. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. S. Waddell, N. T. Liberati, X. Guo, J. P. Frederick, and X.-F. Wang Casein Kinase I{epsilon} Plays a Functional Role in the Transforming Growth Factor-{beta} Signaling Pathway J. Biol. Chem., July 9, 2004; 279(28): 29236 - 29246. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. D. Freedman and K. R. Yamamoto Importin 7 and Importin {alpha}/Importin {beta} Are Nuclear Import Receptors for the Glucocorticoid Receptor Mol. Biol. Cell, May 1, 2004; 15(5): 2276 - 2286. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Zhang, C. J. Duan, C. Binkley, G. Li, M. D. Uhler, C. D. Logsdon, and D. M. Simeone A Transforming Growth Factor {beta}-Induced Smad3/Smad4 Complex Directly Activates Protein Kinase A Mol. Cell. Biol., March 1, 2004; 24(5): 2169 - 2180. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Massague Integration of Smad and MAPK pathways: a link and a linker revisited Genes & Dev., December 15, 2003; 17(24): 2993 - 2997. [Full Text] [PDF] |
||||
![]() |
S. J. Lee, T. Sekimoto, E. Yamashita, E. Nagoshi, A. Nakagawa, N. Imamoto, M. Yoshimura, H. Sakai, K. T. Chong, T. Tsukihara, et al. The Structure of Importin-{beta} Bound to SREBP-2: Nuclear Import of a Transcription Factor Science, November 28, 2003; 302(5650): 1571 - 1575. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Xu, C. Alarcon, S. Col, and J. Massague Distinct Domain Utilization by Smad3 and Smad4 for Nucleoporin Interaction and Nuclear Import J. Biol. Chem., October 24, 2003; 278(43): 42569 - 42577. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Xiao, A. M. Brownawell, I. G. Macara, and H. F. Lodish A Novel Nuclear Export Signal in Smad1 Is Essential for Its Signaling Activity J. Biol. Chem., September 5, 2003; 278(36): 34245 - 34252. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Moren, U. Hellman, Y. Inada, T. Imamura, C.-H. Heldin, and A. Moustakas Differential Ubiquitination Defines the Functional Status of the Tumor Suppressor Smad4 J. Biol. Chem., August 29, 2003; 278(35): 33571 - 33582. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. He, S. B. Tegen, A. R. Krawitz, G. S. Martin, and K. Luo The Transforming Activity of Ski and SnoN Is Dependent on Their Ability to Repress the Activity of Smad Proteins J. Biol. Chem., August 15, 2003; 278(33): 30540 - 30547. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Kurisaki, A. Kurisaki, U. Valcourt, A. A. Terentiev, K. Pardali, P. ten Dijke, C.-H. Heldin, J. Ericsson, and A. Moustakas Nuclear Factor YY1 Inhibits Transforming Growth Factor {beta}- and Bone Morphogenetic Protein-Induced Cell Differentiation Mol. Cell. Biol., July 1, 2003; 23(13): 4494 - 4510. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Liu, M. D. A. Gaca, E. S. Swenson, V. F. Vellucci, M. Reiss, and R. G. Wells Smads 2 and 3 Are Differentially Activated by Transforming Growth Factor-beta (TGF-beta ) in Quiescent and Activated Hepatic Stellate Cells. CONSTITUTIVE NUCLEAR LOCALIZATION OF Smads IN ACTIVATED CELLS IS TGF-beta -INDEPENDENT J. Biol. Chem., March 21, 2003; 278(13): 11721 - 11728. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Tajima, K. Goto, M. Yoshida, K. Shinomiya, T. Sekimoto, Y. Yoneda, K. Miyazono, and T. Imamura Chromosomal Region Maintenance 1 (CRM1)-dependent Nuclear Export of Smad Ubiquitin Regulatory Factor 1 (Smurf1) Is Essential for Negative Regulation of Transforming Growth Factor-beta Signaling by Smad7 J. Biol. Chem., March 14, 2003; 278(12): 10716 - 10721. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. D. Apostolova, I. A. Ivanova, C. Dagnino, S. J. A. D'Souza, and L. Dagnino Active Nuclear Import and Export Pathways Regulate E2F-5 Subcellular Localization J. Biol. Chem., September 6, 2002; 277(37): 34471 - 34479. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Fagerlund, K. Melen, L. Kinnunen, and I. Julkunen Arginine/Lysine-rich Nuclear Localization Signals Mediate Interactions between Dimeric STATs and Importin alpha 5 J. Biol. Chem., August 9, 2002; 277(33): 30072 - 30078. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Moustakas, S. Souchelnytskyi, and C.-H. Heldin Smad regulation in TGF-{beta} signal transduction J. Cell Sci., March 14, 2002; 114(24): 4359 - 4369. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Kusanagi, M. Kawabata, H. K. Mishima, and K. Miyazono alpha -Helix 2 in the Amino-terminal Mad Homology 1 Domain Is Responsible for Specific DNA Binding of Smad3 J. Biol. Chem., July 20, 2001; 276(30): 28155 - 28163. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||